Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.

Sharun K, Tiwari R, Dhama K, Emran TB, Rabaan AA, Al Mutair A

Open source

DOI
10.1080/21645515.2021.1923350
Published
2021 Oct 3
Container
Human vaccines & immunotherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2021.1923350,
  title = {Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.},
  author = {Sharun K and Tiwari R and Dhama K and Emran TB and Rabaan AA and Al Mutair A},
  year = {2021},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2021.1923350},
  url = {https://doi.org/10.1080/21645515.2021.1923350}
}

RIS

TY  - JOUR
TI  - Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.
AU  - Sharun K
AU  - Tiwari R
AU  - Dhama K
AU  - Emran TB
AU  - Rabaan AA
AU  - Al Mutair A
PY  - 2021
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2021.1923350
UR  - https://doi.org/10.1080/21645515.2021.1923350
ER  - 

APA

K, S., R, T., K, D., TB, E., AA, R., & A, A. M. (2021). Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2021.1923350

Source records